Insider Shareholders with Direct Ownership of Nuvalent, Inc. (NUVL)
This section provides a comprehensive overview of the insiders with direct ownership of Nuvalent, Inc. (NUVL). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Nuvalent, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 2,499 | 740,000 | 1,427,197 $120 Million | 25 |
Jun 12, 2024
Added 0.17%
|
|
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
> 10% Shareholder |
897,671 | 0 | 897,671 $75.6 Million | 1 |
Aug 02, 2021
Added 50.0%
|
|
James Richard Porter
President and CEO |
215,800 | 81,000 | 210,113 $17.7 Million | 8 |
Dec 19, 2024
Added 9.48%
|
|
Christopher Durant Turner
Chief Medical Officer |
71,373 | 23,560 | 47,813 $4.03 Million | 14 |
Jan 05, 2024
Added 41.05%
|
|
Alexandra Balcom
Chief Financial Officer |
162,000 | 115,000 | 47,000 $3.96 Million | 18 |
Dec 17, 2024
Added 16.03%
|
|
Henry E. Pelish
Chief Scientific Officer |
23,514 | 43,295 | 43,714 $3.68 Million | 4 |
Dec 16, 2024
Added 9.33%
|
|
Darlene Noci
Chief Development Officer |
235,500 | 202,200 | 33,300 $2.8 Million | 71 |
Nov 01, 2024
Reduced 1.48%
|
|
Deborah Ann Miller
Chief Legal Officer |
183,846 | 150,546 | 33,300 $2.8 Million | 57 |
Sep 16, 2024
Reduced 0.89%
|
| 3,200 | 0 | 3,200 $269,504 | 1 |
Dec 05, 2024
Added 50.0%
|
|
| 39,166 | 36,667 | 2,507 $211,139 | 13 |
Aug 23, 2024
Reduced 57.08%
|
|
| 2,499 | 0 | 2,499 $210,465 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 2,499 | 0 | 2,499 $210,465 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 2,499 | 0 | 2,499 $210,465 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 2,499 | 0 | 2,499 $210,465 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 2,499 | 0 | 2,499 $210,465 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 2,499 | 0 | 2,499 $210,465 | 1 |
Jun 12, 2024
Added 50.0%
|
|
| 7,499 | 5,000 | 2,499 $210,465 | 3 |
Jun 12, 2024
Added 50.0%
|